Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
3,424
archived clinical trials in
Cognitive Studies

Rituximab, Methotrexate, Vincristine Sulfate, Procarbazine Hydrochloride, and Cytarabine With or Without Radiation Therapy in Treating Patients With Primary Central Nervous System Lymphoma
Phase II Randomized Study of Rituximab, Methotrexate, Procarbazine, Vincristine, and Cytarabine With and Without Low-Dose Whole-Brain Radiotherapy for Primary Central Nervous System Lymphoma
Status: Enrolling
Updated:  12/21/2017
University of Maryland Greenebaum Cancer Center
mi
from
Baltimore, MD
Rituximab, Methotrexate, Vincristine Sulfate, Procarbazine Hydrochloride, and Cytarabine With or Without Radiation Therapy in Treating Patients With Primary Central Nervous System Lymphoma
Phase II Randomized Study of Rituximab, Methotrexate, Procarbazine, Vincristine, and Cytarabine With and Without Low-Dose Whole-Brain Radiotherapy for Primary Central Nervous System Lymphoma
Status: Enrolling
Updated: 12/21/2017
University of Maryland Greenebaum Cancer Center
mi
from
Baltimore, MD
Click here to add this to my saved trials
Rituximab, Methotrexate, Vincristine Sulfate, Procarbazine Hydrochloride, and Cytarabine With or Without Radiation Therapy in Treating Patients With Primary Central Nervous System Lymphoma
Phase II Randomized Study of Rituximab, Methotrexate, Procarbazine, Vincristine, and Cytarabine With and Without Low-Dose Whole-Brain Radiotherapy for Primary Central Nervous System Lymphoma
Status: Enrolling
Updated:  12/21/2017
Saint Joseph Mercy Hospital
mi
from
Ann Arbor, MI
Rituximab, Methotrexate, Vincristine Sulfate, Procarbazine Hydrochloride, and Cytarabine With or Without Radiation Therapy in Treating Patients With Primary Central Nervous System Lymphoma
Phase II Randomized Study of Rituximab, Methotrexate, Procarbazine, Vincristine, and Cytarabine With and Without Low-Dose Whole-Brain Radiotherapy for Primary Central Nervous System Lymphoma
Status: Enrolling
Updated: 12/21/2017
Saint Joseph Mercy Hospital
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
Rituximab, Methotrexate, Vincristine Sulfate, Procarbazine Hydrochloride, and Cytarabine With or Without Radiation Therapy in Treating Patients With Primary Central Nervous System Lymphoma
Phase II Randomized Study of Rituximab, Methotrexate, Procarbazine, Vincristine, and Cytarabine With and Without Low-Dose Whole-Brain Radiotherapy for Primary Central Nervous System Lymphoma
Status: Enrolling
Updated:  12/21/2017
West Michigan Cancer Center
mi
from
Kalamazoo, MI
Rituximab, Methotrexate, Vincristine Sulfate, Procarbazine Hydrochloride, and Cytarabine With or Without Radiation Therapy in Treating Patients With Primary Central Nervous System Lymphoma
Phase II Randomized Study of Rituximab, Methotrexate, Procarbazine, Vincristine, and Cytarabine With and Without Low-Dose Whole-Brain Radiotherapy for Primary Central Nervous System Lymphoma
Status: Enrolling
Updated: 12/21/2017
West Michigan Cancer Center
mi
from
Kalamazoo, MI
Click here to add this to my saved trials
Rituximab, Methotrexate, Vincristine Sulfate, Procarbazine Hydrochloride, and Cytarabine With or Without Radiation Therapy in Treating Patients With Primary Central Nervous System Lymphoma
Phase II Randomized Study of Rituximab, Methotrexate, Procarbazine, Vincristine, and Cytarabine With and Without Low-Dose Whole-Brain Radiotherapy for Primary Central Nervous System Lymphoma
Status: Enrolling
Updated:  12/21/2017
Nevada Cancer Research Foundation CCOP
mi
from
Las Vegas, NV
Rituximab, Methotrexate, Vincristine Sulfate, Procarbazine Hydrochloride, and Cytarabine With or Without Radiation Therapy in Treating Patients With Primary Central Nervous System Lymphoma
Phase II Randomized Study of Rituximab, Methotrexate, Procarbazine, Vincristine, and Cytarabine With and Without Low-Dose Whole-Brain Radiotherapy for Primary Central Nervous System Lymphoma
Status: Enrolling
Updated: 12/21/2017
Nevada Cancer Research Foundation CCOP
mi
from
Las Vegas, NV
Click here to add this to my saved trials
Rituximab, Methotrexate, Vincristine Sulfate, Procarbazine Hydrochloride, and Cytarabine With or Without Radiation Therapy in Treating Patients With Primary Central Nervous System Lymphoma
Phase II Randomized Study of Rituximab, Methotrexate, Procarbazine, Vincristine, and Cytarabine With and Without Low-Dose Whole-Brain Radiotherapy for Primary Central Nervous System Lymphoma
Status: Enrolling
Updated:  12/21/2017
Dartmouth Hitchcock Medical Center
mi
from
Lebanon, NH
Rituximab, Methotrexate, Vincristine Sulfate, Procarbazine Hydrochloride, and Cytarabine With or Without Radiation Therapy in Treating Patients With Primary Central Nervous System Lymphoma
Phase II Randomized Study of Rituximab, Methotrexate, Procarbazine, Vincristine, and Cytarabine With and Without Low-Dose Whole-Brain Radiotherapy for Primary Central Nervous System Lymphoma
Status: Enrolling
Updated: 12/21/2017
Dartmouth Hitchcock Medical Center
mi
from
Lebanon, NH
Click here to add this to my saved trials
Rituximab, Methotrexate, Vincristine Sulfate, Procarbazine Hydrochloride, and Cytarabine With or Without Radiation Therapy in Treating Patients With Primary Central Nervous System Lymphoma
Phase II Randomized Study of Rituximab, Methotrexate, Procarbazine, Vincristine, and Cytarabine With and Without Low-Dose Whole-Brain Radiotherapy for Primary Central Nervous System Lymphoma
Status: Enrolling
Updated:  12/21/2017
Memorial Sloan-Kettering Cancer Center - Basking Ridge
mi
from
Basking Ridge, NJ
Rituximab, Methotrexate, Vincristine Sulfate, Procarbazine Hydrochloride, and Cytarabine With or Without Radiation Therapy in Treating Patients With Primary Central Nervous System Lymphoma
Phase II Randomized Study of Rituximab, Methotrexate, Procarbazine, Vincristine, and Cytarabine With and Without Low-Dose Whole-Brain Radiotherapy for Primary Central Nervous System Lymphoma
Status: Enrolling
Updated: 12/21/2017
Memorial Sloan-Kettering Cancer Center - Basking Ridge
mi
from
Basking Ridge, NJ
Click here to add this to my saved trials
Rituximab, Methotrexate, Vincristine Sulfate, Procarbazine Hydrochloride, and Cytarabine With or Without Radiation Therapy in Treating Patients With Primary Central Nervous System Lymphoma
Phase II Randomized Study of Rituximab, Methotrexate, Procarbazine, Vincristine, and Cytarabine With and Without Low-Dose Whole-Brain Radiotherapy for Primary Central Nervous System Lymphoma
Status: Enrolling
Updated:  12/21/2017
Memorial Sloan-Kettering Cancer Center at Commack
mi
from
Commack, NY
Rituximab, Methotrexate, Vincristine Sulfate, Procarbazine Hydrochloride, and Cytarabine With or Without Radiation Therapy in Treating Patients With Primary Central Nervous System Lymphoma
Phase II Randomized Study of Rituximab, Methotrexate, Procarbazine, Vincristine, and Cytarabine With and Without Low-Dose Whole-Brain Radiotherapy for Primary Central Nervous System Lymphoma
Status: Enrolling
Updated: 12/21/2017
Memorial Sloan-Kettering Cancer Center at Commack
mi
from
Commack, NY
Click here to add this to my saved trials
Rituximab, Methotrexate, Vincristine Sulfate, Procarbazine Hydrochloride, and Cytarabine With or Without Radiation Therapy in Treating Patients With Primary Central Nervous System Lymphoma
Phase II Randomized Study of Rituximab, Methotrexate, Procarbazine, Vincristine, and Cytarabine With and Without Low-Dose Whole-Brain Radiotherapy for Primary Central Nervous System Lymphoma
Status: Enrolling
Updated:  12/21/2017
Columbia University Medical Center
mi
from
New York, NY
Rituximab, Methotrexate, Vincristine Sulfate, Procarbazine Hydrochloride, and Cytarabine With or Without Radiation Therapy in Treating Patients With Primary Central Nervous System Lymphoma
Phase II Randomized Study of Rituximab, Methotrexate, Procarbazine, Vincristine, and Cytarabine With and Without Low-Dose Whole-Brain Radiotherapy for Primary Central Nervous System Lymphoma
Status: Enrolling
Updated: 12/21/2017
Columbia University Medical Center
mi
from
New York, NY
Click here to add this to my saved trials
Rituximab, Methotrexate, Vincristine Sulfate, Procarbazine Hydrochloride, and Cytarabine With or Without Radiation Therapy in Treating Patients With Primary Central Nervous System Lymphoma
Phase II Randomized Study of Rituximab, Methotrexate, Procarbazine, Vincristine, and Cytarabine With and Without Low-Dose Whole-Brain Radiotherapy for Primary Central Nervous System Lymphoma
Status: Enrolling
Updated:  12/21/2017
University of Rochester
mi
from
Rochester, NY
Rituximab, Methotrexate, Vincristine Sulfate, Procarbazine Hydrochloride, and Cytarabine With or Without Radiation Therapy in Treating Patients With Primary Central Nervous System Lymphoma
Phase II Randomized Study of Rituximab, Methotrexate, Procarbazine, Vincristine, and Cytarabine With and Without Low-Dose Whole-Brain Radiotherapy for Primary Central Nervous System Lymphoma
Status: Enrolling
Updated: 12/21/2017
University of Rochester
mi
from
Rochester, NY
Click here to add this to my saved trials
Rituximab, Methotrexate, Vincristine Sulfate, Procarbazine Hydrochloride, and Cytarabine With or Without Radiation Therapy in Treating Patients With Primary Central Nervous System Lymphoma
Phase II Randomized Study of Rituximab, Methotrexate, Procarbazine, Vincristine, and Cytarabine With and Without Low-Dose Whole-Brain Radiotherapy for Primary Central Nervous System Lymphoma
Status: Enrolling
Updated:  12/21/2017
University of Cincinnati
mi
from
Cincinnati, OH
Rituximab, Methotrexate, Vincristine Sulfate, Procarbazine Hydrochloride, and Cytarabine With or Without Radiation Therapy in Treating Patients With Primary Central Nervous System Lymphoma
Phase II Randomized Study of Rituximab, Methotrexate, Procarbazine, Vincristine, and Cytarabine With and Without Low-Dose Whole-Brain Radiotherapy for Primary Central Nervous System Lymphoma
Status: Enrolling
Updated: 12/21/2017
University of Cincinnati
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Rituximab, Methotrexate, Vincristine Sulfate, Procarbazine Hydrochloride, and Cytarabine With or Without Radiation Therapy in Treating Patients With Primary Central Nervous System Lymphoma
Phase II Randomized Study of Rituximab, Methotrexate, Procarbazine, Vincristine, and Cytarabine With and Without Low-Dose Whole-Brain Radiotherapy for Primary Central Nervous System Lymphoma
Status: Enrolling
Updated:  12/21/2017
Case Western Reserve Univ
mi
from
Cleveland, OH
Rituximab, Methotrexate, Vincristine Sulfate, Procarbazine Hydrochloride, and Cytarabine With or Without Radiation Therapy in Treating Patients With Primary Central Nervous System Lymphoma
Phase II Randomized Study of Rituximab, Methotrexate, Procarbazine, Vincristine, and Cytarabine With and Without Low-Dose Whole-Brain Radiotherapy for Primary Central Nervous System Lymphoma
Status: Enrolling
Updated: 12/21/2017
Case Western Reserve Univ
mi
from
Cleveland, OH
Click here to add this to my saved trials
Rituximab, Methotrexate, Vincristine Sulfate, Procarbazine Hydrochloride, and Cytarabine With or Without Radiation Therapy in Treating Patients With Primary Central Nervous System Lymphoma
Phase II Randomized Study of Rituximab, Methotrexate, Procarbazine, Vincristine, and Cytarabine With and Without Low-Dose Whole-Brain Radiotherapy for Primary Central Nervous System Lymphoma
Status: Enrolling
Updated:  12/21/2017
Cleveland Clinic Foundation
mi
from
Cleveland, OH
Rituximab, Methotrexate, Vincristine Sulfate, Procarbazine Hydrochloride, and Cytarabine With or Without Radiation Therapy in Treating Patients With Primary Central Nervous System Lymphoma
Phase II Randomized Study of Rituximab, Methotrexate, Procarbazine, Vincristine, and Cytarabine With and Without Low-Dose Whole-Brain Radiotherapy for Primary Central Nervous System Lymphoma
Status: Enrolling
Updated: 12/21/2017
Cleveland Clinic Foundation
mi
from
Cleveland, OH
Click here to add this to my saved trials
Rituximab, Methotrexate, Vincristine Sulfate, Procarbazine Hydrochloride, and Cytarabine With or Without Radiation Therapy in Treating Patients With Primary Central Nervous System Lymphoma
Phase II Randomized Study of Rituximab, Methotrexate, Procarbazine, Vincristine, and Cytarabine With and Without Low-Dose Whole-Brain Radiotherapy for Primary Central Nervous System Lymphoma
Status: Enrolling
Updated:  12/21/2017
University Pointe
mi
from
West Chester, OH
Rituximab, Methotrexate, Vincristine Sulfate, Procarbazine Hydrochloride, and Cytarabine With or Without Radiation Therapy in Treating Patients With Primary Central Nervous System Lymphoma
Phase II Randomized Study of Rituximab, Methotrexate, Procarbazine, Vincristine, and Cytarabine With and Without Low-Dose Whole-Brain Radiotherapy for Primary Central Nervous System Lymphoma
Status: Enrolling
Updated: 12/21/2017
University Pointe
mi
from
West Chester, OH
Click here to add this to my saved trials
Rituximab, Methotrexate, Vincristine Sulfate, Procarbazine Hydrochloride, and Cytarabine With or Without Radiation Therapy in Treating Patients With Primary Central Nervous System Lymphoma
Phase II Randomized Study of Rituximab, Methotrexate, Procarbazine, Vincristine, and Cytarabine With and Without Low-Dose Whole-Brain Radiotherapy for Primary Central Nervous System Lymphoma
Status: Enrolling
Updated:  12/21/2017
Geisinger Medical Center
mi
from
Danville, PA
Rituximab, Methotrexate, Vincristine Sulfate, Procarbazine Hydrochloride, and Cytarabine With or Without Radiation Therapy in Treating Patients With Primary Central Nervous System Lymphoma
Phase II Randomized Study of Rituximab, Methotrexate, Procarbazine, Vincristine, and Cytarabine With and Without Low-Dose Whole-Brain Radiotherapy for Primary Central Nervous System Lymphoma
Status: Enrolling
Updated: 12/21/2017
Geisinger Medical Center
mi
from
Danville, PA
Click here to add this to my saved trials
Rituximab, Methotrexate, Vincristine Sulfate, Procarbazine Hydrochloride, and Cytarabine With or Without Radiation Therapy in Treating Patients With Primary Central Nervous System Lymphoma
Phase II Randomized Study of Rituximab, Methotrexate, Procarbazine, Vincristine, and Cytarabine With and Without Low-Dose Whole-Brain Radiotherapy for Primary Central Nervous System Lymphoma
Status: Enrolling
Updated:  12/21/2017
American College of Radiology Imaging Network
mi
from
Philadelphia, PA
Rituximab, Methotrexate, Vincristine Sulfate, Procarbazine Hydrochloride, and Cytarabine With or Without Radiation Therapy in Treating Patients With Primary Central Nervous System Lymphoma
Phase II Randomized Study of Rituximab, Methotrexate, Procarbazine, Vincristine, and Cytarabine With and Without Low-Dose Whole-Brain Radiotherapy for Primary Central Nervous System Lymphoma
Status: Enrolling
Updated: 12/21/2017
American College of Radiology Imaging Network
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Rituximab, Methotrexate, Vincristine Sulfate, Procarbazine Hydrochloride, and Cytarabine With or Without Radiation Therapy in Treating Patients With Primary Central Nervous System Lymphoma
Phase II Randomized Study of Rituximab, Methotrexate, Procarbazine, Vincristine, and Cytarabine With and Without Low-Dose Whole-Brain Radiotherapy for Primary Central Nervous System Lymphoma
Status: Enrolling
Updated:  12/21/2017
Thomas Jefferson University Hospital
mi
from
Philadelphia, PA
Rituximab, Methotrexate, Vincristine Sulfate, Procarbazine Hydrochloride, and Cytarabine With or Without Radiation Therapy in Treating Patients With Primary Central Nervous System Lymphoma
Phase II Randomized Study of Rituximab, Methotrexate, Procarbazine, Vincristine, and Cytarabine With and Without Low-Dose Whole-Brain Radiotherapy for Primary Central Nervous System Lymphoma
Status: Enrolling
Updated: 12/21/2017
Thomas Jefferson University Hospital
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Rituximab, Methotrexate, Vincristine Sulfate, Procarbazine Hydrochloride, and Cytarabine With or Without Radiation Therapy in Treating Patients With Primary Central Nervous System Lymphoma
Phase II Randomized Study of Rituximab, Methotrexate, Procarbazine, Vincristine, and Cytarabine With and Without Low-Dose Whole-Brain Radiotherapy for Primary Central Nervous System Lymphoma
Status: Enrolling
Updated:  12/21/2017
Geisinger Wyoming Valley/Henry Cancer Center
mi
from
Wilkes-Barre, PA
Rituximab, Methotrexate, Vincristine Sulfate, Procarbazine Hydrochloride, and Cytarabine With or Without Radiation Therapy in Treating Patients With Primary Central Nervous System Lymphoma
Phase II Randomized Study of Rituximab, Methotrexate, Procarbazine, Vincristine, and Cytarabine With and Without Low-Dose Whole-Brain Radiotherapy for Primary Central Nervous System Lymphoma
Status: Enrolling
Updated: 12/21/2017
Geisinger Wyoming Valley/Henry Cancer Center
mi
from
Wilkes-Barre, PA
Click here to add this to my saved trials
Rituximab, Methotrexate, Vincristine Sulfate, Procarbazine Hydrochloride, and Cytarabine With or Without Radiation Therapy in Treating Patients With Primary Central Nervous System Lymphoma
Phase II Randomized Study of Rituximab, Methotrexate, Procarbazine, Vincristine, and Cytarabine With and Without Low-Dose Whole-Brain Radiotherapy for Primary Central Nervous System Lymphoma
Status: Enrolling
Updated:  12/21/2017
M D Anderson Cancer Center CCOP Research Base
mi
from
Houston, TX
Rituximab, Methotrexate, Vincristine Sulfate, Procarbazine Hydrochloride, and Cytarabine With or Without Radiation Therapy in Treating Patients With Primary Central Nervous System Lymphoma
Phase II Randomized Study of Rituximab, Methotrexate, Procarbazine, Vincristine, and Cytarabine With and Without Low-Dose Whole-Brain Radiotherapy for Primary Central Nervous System Lymphoma
Status: Enrolling
Updated: 12/21/2017
M D Anderson Cancer Center CCOP Research Base
mi
from
Houston, TX
Click here to add this to my saved trials
Rituximab, Methotrexate, Vincristine Sulfate, Procarbazine Hydrochloride, and Cytarabine With or Without Radiation Therapy in Treating Patients With Primary Central Nervous System Lymphoma
Phase II Randomized Study of Rituximab, Methotrexate, Procarbazine, Vincristine, and Cytarabine With and Without Low-Dose Whole-Brain Radiotherapy for Primary Central Nervous System Lymphoma
Status: Enrolling
Updated:  12/21/2017
Community Memorial Hospital
mi
from
Menomonee Falls, WI
Rituximab, Methotrexate, Vincristine Sulfate, Procarbazine Hydrochloride, and Cytarabine With or Without Radiation Therapy in Treating Patients With Primary Central Nervous System Lymphoma
Phase II Randomized Study of Rituximab, Methotrexate, Procarbazine, Vincristine, and Cytarabine With and Without Low-Dose Whole-Brain Radiotherapy for Primary Central Nervous System Lymphoma
Status: Enrolling
Updated: 12/21/2017
Community Memorial Hospital
mi
from
Menomonee Falls, WI
Click here to add this to my saved trials
Rituximab, Methotrexate, Vincristine Sulfate, Procarbazine Hydrochloride, and Cytarabine With or Without Radiation Therapy in Treating Patients With Primary Central Nervous System Lymphoma
Phase II Randomized Study of Rituximab, Methotrexate, Procarbazine, Vincristine, and Cytarabine With and Without Low-Dose Whole-Brain Radiotherapy for Primary Central Nervous System Lymphoma
Status: Enrolling
Updated:  12/21/2017
Froedtert and the Medical College of Wisconsin
mi
from
Milwaukee, WI
Rituximab, Methotrexate, Vincristine Sulfate, Procarbazine Hydrochloride, and Cytarabine With or Without Radiation Therapy in Treating Patients With Primary Central Nervous System Lymphoma
Phase II Randomized Study of Rituximab, Methotrexate, Procarbazine, Vincristine, and Cytarabine With and Without Low-Dose Whole-Brain Radiotherapy for Primary Central Nervous System Lymphoma
Status: Enrolling
Updated: 12/21/2017
Froedtert and the Medical College of Wisconsin
mi
from
Milwaukee, WI
Click here to add this to my saved trials
Rituximab, Methotrexate, Vincristine Sulfate, Procarbazine Hydrochloride, and Cytarabine With or Without Radiation Therapy in Treating Patients With Primary Central Nervous System Lymphoma
Phase II Randomized Study of Rituximab, Methotrexate, Procarbazine, Vincristine, and Cytarabine With and Without Low-Dose Whole-Brain Radiotherapy for Primary Central Nervous System Lymphoma
Status: Enrolling
Updated:  12/21/2017
Waukesha Memorial Hospital
mi
from
Waukesha, WI
Rituximab, Methotrexate, Vincristine Sulfate, Procarbazine Hydrochloride, and Cytarabine With or Without Radiation Therapy in Treating Patients With Primary Central Nervous System Lymphoma
Phase II Randomized Study of Rituximab, Methotrexate, Procarbazine, Vincristine, and Cytarabine With and Without Low-Dose Whole-Brain Radiotherapy for Primary Central Nervous System Lymphoma
Status: Enrolling
Updated: 12/21/2017
Waukesha Memorial Hospital
mi
from
Waukesha, WI
Click here to add this to my saved trials
Rituximab, Methotrexate, Vincristine Sulfate, Procarbazine Hydrochloride, and Cytarabine With or Without Radiation Therapy in Treating Patients With Primary Central Nervous System Lymphoma
Phase II Randomized Study of Rituximab, Methotrexate, Procarbazine, Vincristine, and Cytarabine With and Without Low-Dose Whole-Brain Radiotherapy for Primary Central Nervous System Lymphoma
Status: Enrolling
Updated:  12/21/2017
Moffitt Cancer Center
mi
from
Tampa, FL
Rituximab, Methotrexate, Vincristine Sulfate, Procarbazine Hydrochloride, and Cytarabine With or Without Radiation Therapy in Treating Patients With Primary Central Nervous System Lymphoma
Phase II Randomized Study of Rituximab, Methotrexate, Procarbazine, Vincristine, and Cytarabine With and Without Low-Dose Whole-Brain Radiotherapy for Primary Central Nervous System Lymphoma
Status: Enrolling
Updated: 12/21/2017
Moffitt Cancer Center
mi
from
Tampa, FL
Click here to add this to my saved trials
Rituximab, Methotrexate, Vincristine Sulfate, Procarbazine Hydrochloride, and Cytarabine With or Without Radiation Therapy in Treating Patients With Primary Central Nervous System Lymphoma
Phase II Randomized Study of Rituximab, Methotrexate, Procarbazine, Vincristine, and Cytarabine With and Without Low-Dose Whole-Brain Radiotherapy for Primary Central Nervous System Lymphoma
Status: Enrolling
Updated:  12/21/2017
Northwestern University
mi
from
Chicago, IL
Rituximab, Methotrexate, Vincristine Sulfate, Procarbazine Hydrochloride, and Cytarabine With or Without Radiation Therapy in Treating Patients With Primary Central Nervous System Lymphoma
Phase II Randomized Study of Rituximab, Methotrexate, Procarbazine, Vincristine, and Cytarabine With and Without Low-Dose Whole-Brain Radiotherapy for Primary Central Nervous System Lymphoma
Status: Enrolling
Updated: 12/21/2017
Northwestern University
mi
from
Chicago, IL
Click here to add this to my saved trials
Rituximab, Methotrexate, Vincristine Sulfate, Procarbazine Hydrochloride, and Cytarabine With or Without Radiation Therapy in Treating Patients With Primary Central Nervous System Lymphoma
Phase II Randomized Study of Rituximab, Methotrexate, Procarbazine, Vincristine, and Cytarabine With and Without Low-Dose Whole-Brain Radiotherapy for Primary Central Nervous System Lymphoma
Status: Enrolling
Updated:  12/21/2017
Maine Medical Center-Bramhall Campus
mi
from
Portland, ME
Rituximab, Methotrexate, Vincristine Sulfate, Procarbazine Hydrochloride, and Cytarabine With or Without Radiation Therapy in Treating Patients With Primary Central Nervous System Lymphoma
Phase II Randomized Study of Rituximab, Methotrexate, Procarbazine, Vincristine, and Cytarabine With and Without Low-Dose Whole-Brain Radiotherapy for Primary Central Nervous System Lymphoma
Status: Enrolling
Updated: 12/21/2017
Maine Medical Center-Bramhall Campus
mi
from
Portland, ME
Click here to add this to my saved trials
Rituximab, Methotrexate, Vincristine Sulfate, Procarbazine Hydrochloride, and Cytarabine With or Without Radiation Therapy in Treating Patients With Primary Central Nervous System Lymphoma
Phase II Randomized Study of Rituximab, Methotrexate, Procarbazine, Vincristine, and Cytarabine With and Without Low-Dose Whole-Brain Radiotherapy for Primary Central Nervous System Lymphoma
Status: Enrolling
Updated:  12/21/2017
Memorial Sloan Kettering Cancer Center
mi
from
New York, NY
Rituximab, Methotrexate, Vincristine Sulfate, Procarbazine Hydrochloride, and Cytarabine With or Without Radiation Therapy in Treating Patients With Primary Central Nervous System Lymphoma
Phase II Randomized Study of Rituximab, Methotrexate, Procarbazine, Vincristine, and Cytarabine With and Without Low-Dose Whole-Brain Radiotherapy for Primary Central Nervous System Lymphoma
Status: Enrolling
Updated: 12/21/2017
Memorial Sloan Kettering Cancer Center
mi
from
New York, NY
Click here to add this to my saved trials
Rituximab, Methotrexate, Vincristine Sulfate, Procarbazine Hydrochloride, and Cytarabine With or Without Radiation Therapy in Treating Patients With Primary Central Nervous System Lymphoma
Phase II Randomized Study of Rituximab, Methotrexate, Procarbazine, Vincristine, and Cytarabine With and Without Low-Dose Whole-Brain Radiotherapy for Primary Central Nervous System Lymphoma
Status: Enrolling
Updated:  12/21/2017
M D Anderson Cancer Center
mi
from
Houston, TX
Rituximab, Methotrexate, Vincristine Sulfate, Procarbazine Hydrochloride, and Cytarabine With or Without Radiation Therapy in Treating Patients With Primary Central Nervous System Lymphoma
Phase II Randomized Study of Rituximab, Methotrexate, Procarbazine, Vincristine, and Cytarabine With and Without Low-Dose Whole-Brain Radiotherapy for Primary Central Nervous System Lymphoma
Status: Enrolling
Updated: 12/21/2017
M D Anderson Cancer Center
mi
from
Houston, TX
Click here to add this to my saved trials
Rituximab, Methotrexate, Vincristine Sulfate, Procarbazine Hydrochloride, and Cytarabine With or Without Radiation Therapy in Treating Patients With Primary Central Nervous System Lymphoma
Phase II Randomized Study of Rituximab, Methotrexate, Procarbazine, Vincristine, and Cytarabine With and Without Low-Dose Whole-Brain Radiotherapy for Primary Central Nervous System Lymphoma
Status: Enrolling
Updated:  12/21/2017
Tel Aviv Sourasky Medical Center
mi
from
Tel Aviv,
Rituximab, Methotrexate, Vincristine Sulfate, Procarbazine Hydrochloride, and Cytarabine With or Without Radiation Therapy in Treating Patients With Primary Central Nervous System Lymphoma
Phase II Randomized Study of Rituximab, Methotrexate, Procarbazine, Vincristine, and Cytarabine With and Without Low-Dose Whole-Brain Radiotherapy for Primary Central Nervous System Lymphoma
Status: Enrolling
Updated: 12/21/2017
Tel Aviv Sourasky Medical Center
mi
from
Tel Aviv,
Click here to add this to my saved trials
Amyloid and Tauopathy PET Imaging in Acute and Chronic Traumatic Brain Injury
Imaging [18F]AV-1451 and [18F]AV-45 in Acute and Chronic Traumatic Brain Injury
Status: Enrolling
Updated:  1/2/2018
Icahn School of Medicine at Mount Sinai
mi
from
New York, NY
Amyloid and Tauopathy PET Imaging in Acute and Chronic Traumatic Brain Injury
Imaging [18F]AV-1451 and [18F]AV-45 in Acute and Chronic Traumatic Brain Injury
Status: Enrolling
Updated: 1/2/2018
Icahn School of Medicine at Mount Sinai
mi
from
New York, NY
Click here to add this to my saved trials
Cognitive and Functional Connectivity Effects of Methylene Blue in Healthy Aging, Mild Cognitive Impairment and Alzheimer's Disease
Cognitive and Functional Connectivity Effects of Methylene Blue in Healthy Aging, Mild Cognitive Impairment and Alzheimer's Disease
Status: Enrolling
Updated:  1/3/2018
Research Imaging Institute, The University of Texas Health Science Center at San Antonio
mi
from
San Antonio, TX
Cognitive and Functional Connectivity Effects of Methylene Blue in Healthy Aging, Mild Cognitive Impairment and Alzheimer's Disease
Cognitive and Functional Connectivity Effects of Methylene Blue in Healthy Aging, Mild Cognitive Impairment and Alzheimer's Disease
Status: Enrolling
Updated: 1/3/2018
Research Imaging Institute, The University of Texas Health Science Center at San Antonio
mi
from
San Antonio, TX
Click here to add this to my saved trials
Computerized Cognitive Intervention in the Oldest-Old
Computerized Cognitive Intervention in the Oldest-Old: A Feasibility Study
Status: Enrolling
Updated:  1/10/2018
Jewish Home Lifecare
mi
from
New York, NY
Computerized Cognitive Intervention in the Oldest-Old
Computerized Cognitive Intervention in the Oldest-Old: A Feasibility Study
Status: Enrolling
Updated: 1/10/2018
Jewish Home Lifecare
mi
from
New York, NY
Click here to add this to my saved trials
Computerized Cognitive Intervention in the Oldest-Old
Computerized Cognitive Intervention in the Oldest-Old: A Feasibility Study
Status: Enrolling
Updated:  1/10/2018
Icahn School of Medicine at Mount Sinia
mi
from
New York, NY
Computerized Cognitive Intervention in the Oldest-Old
Computerized Cognitive Intervention in the Oldest-Old: A Feasibility Study
Status: Enrolling
Updated: 1/10/2018
Icahn School of Medicine at Mount Sinia
mi
from
New York, NY
Click here to add this to my saved trials
A Pilot Clinical Trial of Exendin-4 in Alzheimer's Disease
A Pilot Study of Exendin-4 in Alzheimer s Disease
Status: Enrolling
Updated:  1/23/2018
National Institute of Aging, Clinical Research Unit
mi
from
Baltimore, MD
A Pilot Clinical Trial of Exendin-4 in Alzheimer's Disease
A Pilot Study of Exendin-4 in Alzheimer s Disease
Status: Enrolling
Updated: 1/23/2018
National Institute of Aging, Clinical Research Unit
mi
from
Baltimore, MD
Click here to add this to my saved trials
Caprylic Triglyceride for Treatment of Cognitive Impairments in Multiple Sclerosis
A Randomized Double-Blind Placebo-Controlled Study of Caprylic Triglyceride for Cognitive Impairment in Subjects With Multiple Sclerosis.
Status: Enrolling
Updated:  1/23/2018
University of Miami Miller School of Medicine
mi
from
Miami, FL
Caprylic Triglyceride for Treatment of Cognitive Impairments in Multiple Sclerosis
A Randomized Double-Blind Placebo-Controlled Study of Caprylic Triglyceride for Cognitive Impairment in Subjects With Multiple Sclerosis.
Status: Enrolling
Updated: 1/23/2018
University of Miami Miller School of Medicine
mi
from
Miami, FL
Click here to add this to my saved trials
Nicotinic Modulation of the Default Network
Nicotinic Modulation of the Default Network of Resting Brain Function
Status: Enrolling
Updated:  1/24/2018
Maryland Psychiatric Research Center
mi
from
Baltimore, MD
Nicotinic Modulation of the Default Network
Nicotinic Modulation of the Default Network of Resting Brain Function
Status: Enrolling
Updated: 1/24/2018
Maryland Psychiatric Research Center
mi
from
Baltimore, MD
Click here to add this to my saved trials
Nicotinic Modulation of the Default Network
Nicotinic Modulation of the Default Network of Resting Brain Function
Status: Enrolling
Updated:  1/24/2018
National Institute on Drug Abuse, Intramural Research Program
mi
from
Baltimore, MD
Nicotinic Modulation of the Default Network
Nicotinic Modulation of the Default Network of Resting Brain Function
Status: Enrolling
Updated: 1/24/2018
National Institute on Drug Abuse, Intramural Research Program
mi
from
Baltimore, MD
Click here to add this to my saved trials
Therapy for Depressed Elders With Thought Problems
PST in Geriatric Depression With Executive Dysfunction
Status: Enrolling
Updated:  1/25/2018
University of California at San Francisco
mi
from
San Francisco, CA
Therapy for Depressed Elders With Thought Problems
PST in Geriatric Depression With Executive Dysfunction
Status: Enrolling
Updated: 1/25/2018
University of California at San Francisco
mi
from
San Francisco, CA
Click here to add this to my saved trials
Therapy for Depressed Elders With Thought Problems
PST in Geriatric Depression With Executive Dysfunction
Status: Enrolling
Updated:  1/25/2018
Weill Medical College of Cornell University
mi
from
White Plains, NY
Therapy for Depressed Elders With Thought Problems
PST in Geriatric Depression With Executive Dysfunction
Status: Enrolling
Updated: 1/25/2018
Weill Medical College of Cornell University
mi
from
White Plains, NY
Click here to add this to my saved trials
Study to Test the Usefulness of Magnetoencephalography (MEG) Imaging of Cognition in Children and Adolescents
Magnetoencephalography (MEG) and Magnetic Resonance Imaging (MRI) Studies of Typical and Atypical Cognitive Processes in Children and Adolescents
Status: Enrolling
Updated:  1/29/2018
Univ of Nebraska Med Ctr
mi
from
Omaha, NE
Study to Test the Usefulness of Magnetoencephalography (MEG) Imaging of Cognition in Children and Adolescents
Magnetoencephalography (MEG) and Magnetic Resonance Imaging (MRI) Studies of Typical and Atypical Cognitive Processes in Children and Adolescents
Status: Enrolling
Updated: 1/29/2018
Univ of Nebraska Med Ctr
mi
from
Omaha, NE
Click here to add this to my saved trials
The Effects of A Proprietary Spearmint Extract on Cognitive Performance
A Randomized, Double-Blind, Placebo-Controlled, Parallel Trial to Assess the Effects of A Proprietary Spearmint Extract on Cognitive Performance, Mood, and Sleep in Men and Women
Status: Enrolling
Updated:  1/29/2018
Musclepharm Sports Science Institute
mi
from
Denver, CO
The Effects of A Proprietary Spearmint Extract on Cognitive Performance
A Randomized, Double-Blind, Placebo-Controlled, Parallel Trial to Assess the Effects of A Proprietary Spearmint Extract on Cognitive Performance, Mood, and Sleep in Men and Women
Status: Enrolling
Updated: 1/29/2018
Musclepharm Sports Science Institute
mi
from
Denver, CO
Click here to add this to my saved trials
Screening for Memory Studies
Screening for Memory Studies
Status: Enrolling
Updated:  1/31/2018
VA Palo Alto Health Care System
mi
from
Palo Alto, CA
Screening for Memory Studies
Screening for Memory Studies
Status: Enrolling
Updated: 1/31/2018
VA Palo Alto Health Care System
mi
from
Palo Alto, CA
Click here to add this to my saved trials
An Investigation of Chemotherapy Induced Cognitive Impairments in Breast Cancer Survivors
An Investigation of Chemotherapy Induced Cognitive Impairments in Breast Cancer
Status: Enrolling
Updated:  2/2/2018
NYU Perlmutter Cancer Center
mi
from
New York, NY
An Investigation of Chemotherapy Induced Cognitive Impairments in Breast Cancer Survivors
An Investigation of Chemotherapy Induced Cognitive Impairments in Breast Cancer
Status: Enrolling
Updated: 2/2/2018
NYU Perlmutter Cancer Center
mi
from
New York, NY
Click here to add this to my saved trials
A Pilot of the Feasibility of Using the Iron-Chelator Deferiprone on Mild Cognitive Impairment
An N of One Clinical Trial to Pilot the Feasibility of Using the Iron-Chelator Deferiprone on Mild Cognitive Impairment
Status: Enrolling
Updated:  2/5/2018
University of Texas Health Science Center
mi
from
San Antonio, TX
A Pilot of the Feasibility of Using the Iron-Chelator Deferiprone on Mild Cognitive Impairment
An N of One Clinical Trial to Pilot the Feasibility of Using the Iron-Chelator Deferiprone on Mild Cognitive Impairment
Status: Enrolling
Updated: 2/5/2018
University of Texas Health Science Center
mi
from
San Antonio, TX
Click here to add this to my saved trials
A Study of Oxytocin for the Treatment of Social Impairment in Individuals With High Functioning Autism Spectrum Disorder
A Pilot Study of Oxytocin for the Treatment of Social Impairment in Individuals With High Functioning Autism Spectrum Disorder
Status: Enrolling
Updated:  2/13/2018
Massachusetts General Hospital
mi
from
Boston, MA
A Study of Oxytocin for the Treatment of Social Impairment in Individuals With High Functioning Autism Spectrum Disorder
A Pilot Study of Oxytocin for the Treatment of Social Impairment in Individuals With High Functioning Autism Spectrum Disorder
Status: Enrolling
Updated: 2/13/2018
Massachusetts General Hospital
mi
from
Boston, MA
Click here to add this to my saved trials
Adult Broad Learning Experiment (ABLE): Feasibility Study
Adult Broad Learning Experiment (ABLE): Feasibility Study
Status: Enrolling
Updated:  2/15/2018
University of California-Riverside
mi
from
Riverside, CA
Adult Broad Learning Experiment (ABLE): Feasibility Study
Adult Broad Learning Experiment (ABLE): Feasibility Study
Status: Enrolling
Updated: 2/15/2018
University of California-Riverside
mi
from
Riverside, CA
Click here to add this to my saved trials
ENLIGHTEN: Exercise and NutritionaL Interventions for coGnitive and Cardiovascular HealTh ENhancement
Lifestyle, CVD Risk, and Cognitive Impairment
Status: Enrolling
Updated:  2/20/2018
Duke Univ Med Ctr
mi
from
Durham, NC
ENLIGHTEN: Exercise and NutritionaL Interventions for coGnitive and Cardiovascular HealTh ENhancement
Lifestyle, CVD Risk, and Cognitive Impairment
Status: Enrolling
Updated: 2/20/2018
Duke Univ Med Ctr
mi
from
Durham, NC
Click here to add this to my saved trials
Optimizing Sleep/Wake Related Cognitive Efficacy
Optimizing Sleep/Wake Related Cognitive Efficacy in Laborist Shifts: Toward Establishing Models of Safer Obstetrical Care
Status: Enrolling
Updated:  2/21/2018
Mayo Clinic Rochester
mi
from
Rochester, MN
Optimizing Sleep/Wake Related Cognitive Efficacy
Optimizing Sleep/Wake Related Cognitive Efficacy in Laborist Shifts: Toward Establishing Models of Safer Obstetrical Care
Status: Enrolling
Updated: 2/21/2018
Mayo Clinic Rochester
mi
from
Rochester, MN
Click here to add this to my saved trials
Critical Illness Myopathy as a Cause of Debilitating ICU-Acquired Weakness
Investigating the Histopathological and Clinical Significance of Critical Illness Myopathy as a Cause of Debilitating ICU-Acquired Weakness
Status: Enrolling
Updated:  2/28/2018
Vanderbilt University
mi
from
Nashville, TN
Critical Illness Myopathy as a Cause of Debilitating ICU-Acquired Weakness
Investigating the Histopathological and Clinical Significance of Critical Illness Myopathy as a Cause of Debilitating ICU-Acquired Weakness
Status: Enrolling
Updated: 2/28/2018
Vanderbilt University
mi
from
Nashville, TN
Click here to add this to my saved trials
Evaluation of DCTclock™ as a Cognitive Assessment Aid
Evaluation of DCTclock™ as a Cognitive Assessment Aid
Status: Enrolling
Updated:  3/5/2018
Compass Research
mi
from
Maitland, FL
Evaluation of DCTclock™ as a Cognitive Assessment Aid
Evaluation of DCTclock™ as a Cognitive Assessment Aid
Status: Enrolling
Updated: 3/5/2018
Compass Research
mi
from
Maitland, FL
Click here to add this to my saved trials
Prevention of Depression in Spouses of People With Cognitive Impairment
Prevention of Psychiatric Morbidity in AD Caregivers
Status: Enrolling
Updated:  3/6/2018
University of Pittsburgh Alzheimer's Disease Research Center (ADRC)
mi
from
Pittsburgh, PA
Prevention of Depression in Spouses of People With Cognitive Impairment
Prevention of Psychiatric Morbidity in AD Caregivers
Status: Enrolling
Updated: 3/6/2018
University of Pittsburgh Alzheimer's Disease Research Center (ADRC)
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Prevention of Depression in Spouses of People With Cognitive Impairment
Prevention of Psychiatric Morbidity in AD Caregivers
Status: Enrolling
Updated:  3/6/2018
Duquesne Univeristy
mi
from
Pittsburgh, PA
Prevention of Depression in Spouses of People With Cognitive Impairment
Prevention of Psychiatric Morbidity in AD Caregivers
Status: Enrolling
Updated: 3/6/2018
Duquesne Univeristy
mi
from
Pittsburgh, PA
Click here to add this to my saved trials